专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明专利

JP2007091730A Preventing or alleviating agent of asthenopia 有权
标题翻译：预防或治疗哮喘患者
公开(公告)号：JP2007091730A
公开(公告)日：2007-04-12
申请号：JP2006232942
申请日：2006-08-30
申请人： Taisho Pharmaceut Co Ltd , 大正製薬株式会社
发明人： MORITO AKIHISA , UMAKADO KAZUMI , KURACHI MICHIO
IPC分类号： A61K36/29 , A23L1/30 , A61P27/02
摘要： PROBLEM TO BE SOLVED: To provide a drug, quasi drug or food effective for the prevention and alleviation of retinopathy caused by light or aging and asthenopia caused by the retinopathy and having high safety, even on using for a long period. SOLUTION: This preventing or alleviating agent of the retinopathy is characterized by blending dried plants belonging to the genus Epimedium. The oral preparation for preventing and alleviating the asthenopia is characterized by blending the dried plants belonging to the genus Epimedium. Thereby, the drug, quasi drug and food useful for the prevention and alleviation of the retinopathy and asthenopia caused by the retinopathy are provided. COPYRIGHT: (C)2007,JPO&INPIT
摘要翻译：要解决的问题：提供一种药物，准药物或食品，有效预防和减轻由视网膜病变引起的光或老化和视力失调引起的视网膜病变，并具有高安全性，甚至长时间使用。解决方案：这种视网膜病变的预防或缓解剂的特征在于混合属于淫羊藿属的干燥植物。预防和减轻眼疲劳的口服制剂的特征在于混合属于淫羊藿属的干燥植物。因此，提供了用于预防和减轻由视网膜病变引起的视网膜病变和眼疲劳的药物，准药物和食品。版权所有（C）2007，JPO＆INPIT

2. 发明专利

JP2007091729A Exocrine functional disorder-improving agent 有权
标题翻译： EXOCRINE功能障碍改善剂
公开(公告)号：JP2007091729A
公开(公告)日：2007-04-12
申请号：JP2006232941
申请日：2006-08-30
申请人： Taisho Pharmaceut Co Ltd , 大正製薬株式会社
发明人： MORITO AKIHISA , UMAKADO KAZUMI
IPC分类号： A61K36/18 , A61P1/02 , A61P27/04
摘要： PROBLEM TO BE SOLVED: To provide an exocrine functional disorder-improving agent effective for the prevention and improvement of dry eye or dry mouth, and having high safety.
SOLUTION: This exocrine functional disorder-improving agent is characterized by blending betel nut. The preventing and improving agent of the dry mouth is characterized by blending the betel nut. The preventing and improving agent of the dry eye is characterized by blending the betel nut. The exocrine functional disorder-improving agent is useful as the drug, quasi drug or food for preventing or improving the dry eye or dry mouth.
COPYRIGHT: (C)2007,JPO&INPIT
摘要翻译：要解决的问题：提供对预防和改善干眼症或口干有效并具有高安全性的外分泌功能障碍改善剂。解决方案：这种外分泌功能障碍改善剂的特征是混合槟榔。口干预防和改善剂的特征是混合槟榔。干眼症的预防和改善剂的特征在于混合槟榔。外分泌功能障碍改善剂可用作预防或改善干眼或口干的药物，准药物或食物。版权所有（C）2007，JPO＆INPIT

3. 发明专利

JP2007091728A Oral preparation for preventing or alleviating asthenopia 有权
标题翻译：用于预防或治疗哮喘的口服制剂
公开(公告)号：JP2007091728A
公开(公告)日：2007-04-12
申请号：JP2006232940
申请日：2006-08-30
申请人： Taisho Pharmaceut Co Ltd , 大正製薬株式会社
发明人： MORITO AKIHISA , UMAKADO KAZUMI , KURACHI MICHIO
IPC分类号： A61K36/53 , A61P27/02
摘要： PROBLEM TO BE SOLVED: To provide an oral preparation effective for the prevention and alleviation of retinopathy caused by light or aging and asthenopia caused by the retinopathy and having high safety, even on using for a long period.
SOLUTION: This oral preparation for preventing or alleviating the retinopathy is characterized by blending peppermint. The oral preparation for preventing and alleviating the asthenopia is characterized by blending the peppermint. Thereby, the oral preparation is useful as a drug, quasi drug and food for the prevention and alleviation of the retinopathy and asthenopia caused by the retinopathy.
COPYRIGHT: (C)2007,JPO&INPIT
摘要翻译：要解决的问题：提供一种有效预防和缓解由视网膜病变引起的光或老化和视力失调导致的视网膜病变并且具有高安全性的口服制剂，即使长时间使用也是如此。解决方案：用于预防或减轻视网膜病变的口服制剂的特征在于混合薄荷糖。预防和减轻眼疲劳的口服制剂的特征在于混合薄荷糖。因此，口服制剂可用作预防和缓解由视网膜病变引起的视网膜病变和眼疲劳的药物，准药物和食物。版权所有（C）2007，JPO＆INPIT

4. 发明专利

JP2007091727A Preventing or alleviating agent of asthenopia 有权
标题翻译：预防或治疗哮喘患者
公开(公告)号：JP2007091727A
公开(公告)日：2007-04-12
申请号：JP2006232939
申请日：2006-08-30
申请人： Taisho Pharmaceut Co Ltd , 大正製薬株式会社
发明人： MORITO AKIHISA , UMAKADO KAZUMI , KURACHI MICHIO
IPC分类号： A61K36/48 , A61P27/02
摘要： PROBLEM TO BE SOLVED: To provide a drug, quasi drug or food, effective for the prevention and alleviation of retinopathy caused by light or aging and asthenopia caused by the retinopathy, and having high safety even on using for a long period.
SOLUTION: This preventing or alleviating agent of retinopathy is characterized by blending red clover. The preventing and alleviating agent of asthenopia is characterized by blending the red clover. Thereby, the drug, quasi drug and food useful for the prevention and alleviation of the retinopathy and asthenopia caused by the retinopathy are provided.
COPYRIGHT: (C)2007,JPO&INPIT
摘要翻译：要解决的问题：提供一种有效预防和缓解由视网膜病变引起的光或衰老和眼疲劳引起的视网膜病变的药物，准药物或食品，并且即使长时间使用也具有高安全性。解决方案：这种视网膜病变的预防或缓解剂的特征在于混合红三叶草。透视的预防和缓解剂的特点是混合红三叶草。因此，提供了用于预防和减轻由视网膜病变引起的视网膜病变和眼疲劳的药物，准药物和食品。版权所有（C）2007，JPO＆INPIT

5. 发明专利

JP2005162745A Ameliorating agent for hypertension 有权
标题翻译：高分子化合物
公开(公告)号：JP2005162745A
公开(公告)日：2005-06-23
申请号：JP2004327310
申请日：2004-11-11
申请人： Taisho Pharmaceut Co Ltd , 大正製薬株式会社
发明人： UMAKADO KAZUMI , KURACHI MICHIO , TAKENAGA TAKAAKI
IPC分类号： A23L1/30 , A61K36/18 , A61P9/12 , C12N9/99 , A61K35/78
摘要： PROBLEM TO BE SOLVED: To obtain an oral composition capable of treating and preventing hypertension, capable of ameliorating symptoms accompanied with the hypertension, such as vertigo, ear noise, headache, shortness of breath, numbness of hand and foot, flush of face, perspiration of palm, fever, general physical weariness, decrease in physical strength, giddiness, stiffness in shoulders, joint and muscular pain, poor falling asleep and sleeplessness, anxiety, solitary feeling, decrease in concentration, and decrease in eagerness, and safe even when administered for a long period. SOLUTION: The subject ameliorating agent for the hypertension is formed by mixing Piper longum thereinto. An angiotensin activity inhibitor is formed by the same manner. The agent for the hypertension which is safe, even when administered for the long period, and has enough efficacy is obtained by this method. Further, a medicine, a functional food, a food, a supplement, and the like, are obtained by using the same. COPYRIGHT: (C)2005,JPO&NCIPI
摘要翻译：待解决的问题：为了获得能够治疗和预防高血压的口服组合物，其能够改善伴有高血压的症状，例如眩晕，耳朵噪音，头痛，呼吸短促，手脚麻痹，冲洗手掌发热，身体疲劳，身体疲惫，身体力量下降，肩胛骨僵硬，关节和肌肉疼痛，睡眠不足，睡眠不安，焦虑，孤独感，浓度降低，急速下降，安全即使长时间施用。解决方案：用于高血压的受试者改善剂是通过将琵琶长混合而形成的。通过相同的方式形成血管紧张素活性抑制剂。通过该方法可获得安全的高血压药物，即使长时间给药，具有足够的功效。此外，通过使用它们可以获得药物，功能食品，食品，补充剂等。版权所有（C）2005，JPO＆NCIPI

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式